02-10-2020
Piotr Swat / Shutterstock.com
A US appeals court has cancelled a $448 million antitrust bill for AbbVie, in a blow for the US Federal Trade Commission (FTC).
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
FTC, AbbVie, antitrust, US District Court for the Eastern District of Pennsylvania, Besins healthcare, monopoly, FDA, reverse payment, lawsuit, en banc
